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Elucidating the mechanism of chain termination switching in the 
picromycin/methymycin polyketide synthase 
Li Tang, Hong Fu, Melanie C Betlach and Robert McDaniel 
Background: A single modular polyketide synthase (PKS) gene cluster is 
responsible for production of both the 14-membered macrolide antibiotic 
picromycin and the 1 P-membered macrolide antibiotic methymycin in 
Streptomyces venezuelae. Building on the success of the heterologous 
expression system engineered using the erythromycin PKS, we have constructed 
an analogous system for the picromycin/methymycin PKS. Through heterologous 
expression and construction of a hybrid PKS, we have examined the contributions 
that the PKS, its internal thioesterase domain (pikTE) and the Pik TEII thioesterase 
domain make in termination and cyclization of the two polyketide intermediates, 
Results: The picromycin/methymycin PKS genes were functionally expressed in 
the heterologous host Streptomyces lividans, resulting in production of both 
narbonolide and 1 0-deoxymethynolide (the precursors of picromycin and 
methymycin, respectively). Co-expression with the Pik TEII thioesterase led to 
increased production levels, but did not change the ratio of the two compounds 
produced, leaving the function of this protein largely unknown. Fusion of the PKS 
thioesterase domain (pikTE) to 6deoxyerythronolide B synthase (DEBS) resulted 
in formation of only 14-membered macrolactones. 
Conclusions: These experiments demonstrate that the PKS alone is capable of 
catalyzing the synthesis of both 14- and 12-membered macrolactones and favor 
a model by which different macrolactone rings result from a combination of the 
arrangement between the module 5 and module 6 subunits in the picromycin 
PKS complex and the selectivity of the pikTE domain. 
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Introduction 
Modular polyketide synthases (PKSs) are responsible for 
producing a large number of 12, 14- and 16-membered 
macrolide antibiotics including methymycin, erythromycin 
and tylosin. These large, multifunctional enzymes 
(>300,000 kDa) catalyze the biosynthesis of polyketide 
macrolactones through multistep pathways involving 
decarboxylative condensations between acyl thioesters fol- 
lowed by cycles of varying B-carbon processing [l]. The 
ability to control aspects of polyketide biosynthesis, such 
as monomer selection, degree of B-carbon processing and 
stereoselectivity, by genetic manipulation of PKSs has 
stimulated great interest in the combinatorial engineering 
of novel antibiotics [2,3]. Picromycin (1; Figure 1) is of par- 
ticular interest for such use because of its close structural 
relationship to ketolide compounds (e.g. HMR 3004), a 
new class of semisynthetic macrolides with activity against 
pathogens resistant to erythromycin [4]. Genetic systems 
that allow rapid engineering of the picromycin PKS would 
therefore be valuable for creating novel ketolide analogs 
for pharmaceutical applications. 
A pivotal development for modular PKS engineering was 
the heterologous expression of the erythromycin PKS 
(6-deoxyerythronolide B synthase, DEBS) in Streptomyces 
coelicolor [5,6]. The advantages to this plasmid-based 
genetic system for DEBS were that it overcame the 
tedious and limited techniques for manipulating the 
natural DEBS host organism, Saccharopolyspora etythaea, it 
allowed more facile construction of mutant PKSs, and it 
reduced the complexity of PKS property analysis by pro- 
viding a ‘clean’ host background. This system also expe- 
dited the construction of the first combinatorial modular 
polyketide library in Streptomyces [7]. Despite the success 
of this system, as well as the increased number of modular 
PKS gene clusters currently available, DEBS remained 
the only modular PKS reported to be expressed in a het- 
erologous organism. 
The picromycin gene cluster from Streptomyces venezuelae 
was recently cloned and sequenced by Sherman and 
coworkers [8] and in our own laboratories ([9]; M.C.B., 
unpublished observations). S. venezuelae is unique among 
macrolide-producing organisms because it produces 
primary polyketides with two different ring sizes. In addi- 
tion to the 14-membered macrolide picromycin (l), the 
12-membered macrolide methymycin (2; Figure 1) is also 
produced. Based on the structural similarities between 
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Structures of picromycin and methymycin. 
picromycin and methymycin, it was speculated that 
methymycin would result from premature cyclization of a 
hexaketide intermediate in the picromycin pathway 
(Figure 2). Gene-disruption experiments have since con- 
firmed that the same PKS is indeed responsible for pro- 
ducing the polyketide precursors to both compounds [8]. 
Although the mechanism for this dual polyketide chain- 
length specificity is not currently understood, analysis of 
the gene cluster has generated some hypotheses. Xue et&. 
[8] postulated that a separate external thioesterase (Pik 
TEII, Figure 3) located immediately downstream of the 
PKS might play a role in chain-length control. However, 
homologs of this enzyme are found in other macrolide 
Figure 2 
gene clusters, such as erythromycin and tylosin, that do 
not produce analogs with alternative ring sizes [lo,1 11. 
Another possible explanation is that the covalent uncou- 
pling of the two terminal modules (modules 5 and 6) could 
result in subunit complexes that promote cyclization of 
either intermediate. This mechanism was suggested to 
explain the premature release of triketide products from a 
trimodular DEBS system in vitro [IZ]. 
We have developed a plasmid-based expression system 
for the picromycin PKS as a complementary system to 
DEBS for studying macrolide PKSs. Heterologous expres- 
sion of the complete picromycin PKS in Streptomyces && 
dam allowed us to examine the inherent ring-size 
specificity of the picromycin PKS and the influence that 
various PKS-associated thioesterases have in the formation 
of polyketide structures. 
Results and discussion 
Construction of a picromycin PKS expression system 
The vector used for expression of the picromycin PKS is 
analogous to that developed for DEBS [5]. The three 
DEBS open reading frames (ORFs) in pCK7 [5] were 
replaced with all four picromycin PKS ORFs to generate 
pKOS039-86. Like pCK7, pKOS039-86 is a shuttle vector 
that permits rapid manipulation in E.&en&a cor’i and 
expression in Streptomyces. The host strain selected for this 
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Modular arrangement of the picromycin/methymycin PKS. The 
picromycin PKS consists of six modules, a loading domain and a 
thioesterase (TE) domain on four separate polypeptides. Each module 
possesses a ketosynthase (KS), acyltransferase (AT) and acyl carrier 
protein (ACP) domain, which together catalyze addition of each 
extender unit. Narbonolide (3) the polyketide precursor to picromycin 
(1) is derived from six propionates (loading, modules 1,3,4,5,6) and 
one acetate (module 2). Modules 1, 5 and 6 contain a ketoreductase 
(KR) domain for P-keto processing, modules 3 and 6 have no 
functional bketo processing domains, module 2 contains KR and 
dehydratase (DH) domains, and module 4 contains KR, DH and enoyl 
reductase (ER) domains. 1 0-Deoxymethynolide (4) results from 
premature cyclization of the hexaketide intermediate from module 5. 
K.Soi domain homologous to KS but which contains an active-site 
cysteine to glutamine mutation. The entire PKS gene cluster was 
subcloned to create expression plasmid pKOS039-86. 
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Organization of the picromycinlmethymycin PK!S genes and thiioesterase domains. The extemaf th&sterase, Pik TEU, is encoded asavate 
polypeptide. The function of thii daaa of thioesterase Protein found in macroWe gene clusters is unknawn. 
study was S. hidans K4-114 [13], which contains a dele- 
tion of the entire actinorhodin (act) polyketide gene 
cluster and produces no known macrolides. This strain has 
a high transformation efficiency and a relatively low 
restriction barrier, eliminating the need to first pass the 
DNA through methylase-deficient strains, as is required 
for most SlrpZomyces species. 
lhetpbomycinPKSproduces12-andlemernbered 
me 
Transformation of S. hidam K4-114 with plasmid 
pKOS039-86 resulted in a strain that produced two com- 
pounds in similar yield (-5-10 mg/l each). Analysis of fer- 
mentation extracts using liquid chromatography/mass 
spectrometry (LC/MS) and rH nuclear magnetic reso- 
nance (NMR) spectroscopy of the purified compounds 
established their identities as narbonolide (3) (141 and 
IO-deoxymethynolide (4) [15], the respective 14 and 
1 Z-membered polyketide precursors of picromycin (1) and 
methymycin (2; Figure 2). 
The production of narbonolide in S. lividan represents 
the second reported expression of an entire modular 
polyketide pathway in a heterologous host. The combined 
yields of the two polyketides are similar to those obtained 
with expression of DEBS from pCK7 (51. Furthermore, 
the -1:l ratio of narbonolide (3) to lO-deoxymethynolide 
(4) produced suggests that the picromycin PKS itself pos- 
sesses an inherent ability to produce both 12- and 
14membered macrolactones without the requirement of 
additional activities unique to 5. vcmwe/ae. Although we 
cannot rule out the existence of a complementary enzyme 
present in S. &dam that provides this function, it would 
be unusual to find such a specific enzyme in an organism 
that does not produce any macrolide. 
~rcthlhapeklEllth~ 
The possible role of the Pik TEJI enzyme in 
picromycin/methymycin biosynthesis was examined by 
co-expressing this enzyme with the picromycin PKS. The 
pihAV gene encoding Pik TEII (Figure 3) was cloned into 
a &+~~ces genome-integrating vector under control of 
the same promoter (Pa& [5,6] that drives expression of 
the PKS. Transformation of S. hvidans K4-114 with this 
vector resulted in S. lividam K39-18. 
A comparison of strains K39-18/pKOSO39-86 and 
K4-114/pKOS039-86 grown under identical conditions 
indicated that the strain containing Pik TEII produced 
4-7 times more total polyketide. This indicates that the 
enzyme is functional in this strain and is consistent with the 
observation by Xue d al. 181 who report that yields fall to 
below 5% for both picromycin and methymycin when 
picAV is disrupted in S. venau&ze. However, the production 
levels of narbonolide (3) and IO-deoxymethynobde (4) 
from K39-181pKOSO3986 increased by the same relative 
amounts, indicating that Pik TEII does not appear to influ- 
ence the ratio of 12- to 14membered lactone ring fmma- 
tion. The effect of Pik TEL1 on Gdeoxyerythronolide B 
(6dEB) production by DEBS was also tested by co-expres- 
sion. S. /ividanr K39-18 transformed with pCK7 failed to 
produce any I&membered macrolide and had little or no 
effect on production levels of 6-dEB. 
At present it remains unclear what function Pik TEII or 
its homologs provide during polyketide biosynthesis. 
Similar observations have prompted others t16,lfl to 
propose that such thioesterase domains might serve as 
‘editing’ enzymes that release aberrant thioesters from the 
PKS blocking polyketide synthesis. If so, the above result 
suggests that these enzymes may have some specificity 
towards their cognate PKS complexes in order to provide 
optimal activity. 
We examined whether the thioesterase domain encoded by 
the PKS (pikTE) could promote formation of 1 Z-mem- 
bered lactones in the context of a different PKS. A con- 
struct was generated, pKOSO39-18, in which pikTE was 
fused with DEBS in place of its native thioesterase domain 
(Figure 4). In order to allow the pikTE to distinguish 
between substrates most closely resembling those gener- 
ated by the picromycin PKS, the fusion junction was 
chosen between eryAT6 and picACP6 in order to eliminate 
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Figure 4 
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DEBS/pikTE hybrid PKS and polyketide product. Replacement of the DEBS TE domain with the pikTE domain leads to production of the expected 
14-membered macrolide, but no 1 P-membered macrolides are generated. pKOS039-18 is the plasmid construct that expresses the hybrid PKS. 
ketoreductase activity in module 6. This results in a mutant 
PKS that presents the pikTE with a b-keto heptaketide 
intermediate and a p-Whydroxy hexaketide intermediate 
to cyclize, as in narbonolide or lo-deoxymethynolide 
biosynthesis. Analysis of the compounds generated by this 
construct indicated the production of the 14-membered 
ketolide 3,6-dideoxy-3-oxo-erythronolide B (5) [7], but the 
predicted 1 Z-membered macrolactone, (8R,9S)-8,9- 
dihydro-8-methyl-9-hydroxy-lo-deoxymethynolide - the 
product of a pentamodular DEBS system (6) [18] -was 
not detected (Figure 4). The pikTE domain, therefore, is 
incapable of forcing premature cyclization of the hexake- 
tide intermediate generated by DEBS. 
The cumulative results reported here indicate that the 
thioesterases found in the pik gene cluster do not deter- 
mine the length of the polyketide chain and lend support 
to the notion that protein interactions between the module 
5 and module 6 + TE subunits of the picromycin PKS play 
a role in formation of the two macrolides. This is consistent 
with recent in vitro studies by Gokhale etal. [19] using the 
DEBS thioesterase domain. They demonstrated that a 
DEBS module 3 + TE subunit could catalyze triketide 
cyclization from DEBSl with tenfold higher turnover 
when compared to the DEBS TE domain alone. This sug- 
gested that interactions between DEBSl and module 3 
established a route for premature cyclization. If so, our 
results provide evidence that the decision by the pikTE 
domain to cyclize either a hexaketide or heptaketide inter- 
mediate is mediated by the formation of protein complexes 
between modules 5 and 6 of DEBS or the picromycin PKS. 
Together these studies support a general mechanistic 
model for polyketide chain termination in which interac- 
tions between modules or subunits in combination with 
the selectivity of thioesterase domains control the point of 
chain termination. 
Utility of picromycin PKWDEBS hybrid engineering 
The above example illustrates how related modular 
polyketide gene clusters can be combined to gain insights 
into the basis of particular enzyme functions or specifici- 
ties. The similarities between the picromycin and ery- 
thromycin pathways make them a very compatible system 
for hybrid engineering. The expression tool described 
here will facilitate the study of these pathways where dif- 
ferences occur or the pathways diverge. In the example 
above, it demonstrates utility for the ‘fine tuning’ of novel 
polyketide engineering. Compound 5 was originally gen- 
erated by deletion of the KR6 domain in DEBS in an 
attempt to engineer a 3-ketolide-producing PKS [7]. 
Although the desired molecule was made, purification 
from this strain was hampered by the unexpected pres- 
ence of Z-desmethyl ketolides that could not be easily 
separated. Extracts from S. lividam K4-114/pKOS039-18, 
however, do not contain the Z-desmethyl compounds, 
greatly simplifying purification. 
Significance 
The heterologous expression system used in this study 
was originally developed with the erythromycin polyketide 
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synthase (PKS). It has been a valuable tool for examin- 
ing properties of modular PKSs because it allows rapid 
genetic engineering and expression of mutant PKSs. 
Despite the number of modular gene cluster sequences 
that have been reported since this development, no 
other examples of heterologous expression of modular 
PKSs have been reported. We have functionally 
expressed the complete picromycin PKS in the polyke- 
tide ‘clean’ host S. lividans K4-114, demonstrating 
the universal applicability of this system for modular 
PKS engineering. We have shown that the picromycin 
PKS alone is capable of producing both 12- and 
14-membered macrolides without a requirement for any 
other activities. The unique dual specificity of the 
picromycin PKS allowed us to probe the mechanism by 
which different polyketide chain lengths can be synthe- 
sized by a single modular PKS. Experiments with the 
pikTE domain and the Pik TEII thioesterase domain 
suggest that subunit interactions between PKS modules 
appear to be the underlying determinant for this switch 
rather than the selectivity of thioesterase domains. We 
also confirm that TEII proteins, which are present in 
all macrolide gene clusters, may be important for 
optimal turnover of PKSs. 
Materials and methods 
Bacterial strains and culture conditions 
DNA manipulations were performed in E. co/i XL1 Blue (Stratagene) 
using standard culture conditions. S. lividam K4-114 [13] or S. /iv;- 
dam K39-18 (reported here) were used as hosts for expression of 
engineered PKSs. S. lividans K39-18 is derived from S. hvidans 
K4-114 and contains an integrated copy of plasmid pKOS39-44 (see 
below). S. hvidans transformants were grown on RPYE [20] agar 
plates with appropriate antibiotic selection. Liquid R2YE + 2 pglml 
thiostrepton was used for production of polyketides. 
Manipulation of DNA and organisms 
Manipulation and transformation of DNA in f. co/i was performed using 
standard procedures [21]. The polymerase chain reaction (PCR) was 
performed using Pfu polymerase (Stratagene) under conditions recom- 
mended by the manufacturer. S. lividans protoplasts were transformed 
using the standard procedure [20]. Transformants with PKS expression 
plasmids were selected using 1 ml of a 1 mglml thiostrepton overlay 
when using S. lividam K4-114 and 1 mglml thiostrepton + 2 mg/ml 
apramycin overlay when using S. lividans K39-18. 
Construction of PKS expression plasmids pKOSO39- 18 and 
pKOSO39-86 
The picromycin PKS expression plasmid, pKOS039-86, is a derivative 
of pCK7 in which the DEBS genes encoded between the Ndel site and 
EcoRl site have been replaced by the picAl-IVgenes using conventional 
multistep cloning procedures. There is also an additional kanamycin 
antibiotic resistance marker cloned into the HindIll site of pCK7. 
The pikACPG-TE domain used in construction of plasmid pKOS039-18 
was PCR amplified using the following oligonucleotides (cloning sites 
in italics); forward 5’sTlTATGCATCCCGCGGGTCCCGGCGAG-3’ 
and reverse 5’-TCAGAA77CTGTCGGTCACTTGCCCGC~3’. 
Expression plasmid pKOS39-18 was constructed by replacing the 
eryKR6 + ACP6 + TE domains of DEBS with the picACP6-TE Nsil- 
EcoRl fragment in a pCK7 derivative containing an engineered Pstl site 
at the end of eryAT6 boundary [71. 
Construction of the pikTEll integrating vector 
The pi/&V gene was PCR amplified from cosmid pKOS023-27 [9] 
using the following oligonucleotide primers (engineered cloning sites 
in italics): forward 5’-GTCATATGCTGGCTCGACGCCATCGAGG- 
GCA-3’ and reverse 5’-CCTCTAGAGGTCGTCGGTCACCGTGG- 
GTTCTGCCA-3’. 
Plasmid pKOS39-44 contains the Ndel-Xbal fragment of the cloned 
pikAV gene inserted into the NdellSpel sites of pKOSOlO-157 
(R. Zierman and M.C.B., unpublished observations), a pSET152 [22] 
based integrating vector. This results in a vector which contains the 
same 2.8 kb HindIll-Ndel fragment from pCK7 [5], containing the 
a&II-4 transcriptional activator and Pacd promoter, upstream of pikAV. 
Analysis of polyketide-producing cultures 
Samples of fermentation broth (0.25-l ml) were loaded onto to a 
(0.46 x 1 cm) C-l 8 precolumn, washed with approximately 5 volumes 
of water and eluted directly onto a (0.46 x 14 cm) C-l 8 high perfor- 
mance liquid chromatography (HPLC) column with a O-l 00% acetoni- 
trile in water gradient. Detection was performed with atmospheric 
pressure chemical ionization (APCI) mass spectrometry (LCIMS) for 
component analysis and light scattering detection (ELSD) for quantita- 
tion. Authentic samples of narbonolide (3) and 1 O-deoxymethynolide 
(4) were prepared as described below. A previously purified sample of 
3,6-dideoxy-3-oxo-erythronolide B (5) 171 was also used for compari- 
son. The mass and retention time of identified compounds matched 
those of the standards. 
Purification and characterization of narbonolide (3) and 
1 0-deoxymethynolide (4) 
A 2 I shake flask culture of S. lividans K4-114/pKOS039-86 was grown 
for 7 days at 30°C. The mycelia was filtered and the aqueous layer was 
extracted with 2 x 2 I ethyl acetate. The organic layers were combined, 
dried over MgSO,, filtered and evaporated to dryness. Polyketides 
were separated from the crude extract using silica gel chromatography 
(1:4 to 1:2 ethyl acetate:hexane gradient) to give a 10 mg mixture of 
narbonolide and 1 0-deoxymethynolide, as indicated by LClMS and ‘H 
NMR. Purification of these two compounds was achieved by HPLC on 
a C-18 reverse phase column (20-80% acetonitrile in water over 
45 min). This procedure yielded -5 mg each of narbonolide (3) and 
IO-deoxymethynolide (4). The ‘-H NMR (300 MHz) spectra of both 
compounds were identical to those previously reported [14,151. 
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